Skip to main content

Gerard Cantero Recasens

I am a Principal Investigator of the Renal Physiopathology Group at Vall d'Hebron Research Institute (VHIR) in Barcelona. Motivated by my deep interest in understanding how ion signalling impacts cellular homeostasis and its pathological implications, I have cultivated over the years a diverse skill set including electrophysiology, biochemistry, live-cell imaging, molecular biology, and cell biology. My primary research focus lies in unravelling the intricate relationship between ion homeostasis, glycosylation, and protein trafficking under both physiological and pathological conditions, with a particular emphasis on renal diseases.

Institutions of which they are part

Main researcher
Kidney Physiopathology
Vall Hebron Institut de Recerca
Gerard Cantero Recasens

Gerard Cantero Recasens

Gerard Cantero Recasens

Institutions of which they are part

Main researcher
Kidney Physiopathology
Vall Hebron Institut de Recerca

I am a Principal Investigator of the Renal Physiopathology Group at Vall d'Hebron Research Institute (VHIR) in Barcelona. Motivated by my deep interest in understanding how ion signalling impacts cellular homeostasis and its pathological implications, I have cultivated over the years a diverse skill set including electrophysiology, biochemistry, live-cell imaging, molecular biology, and cell biology. My primary research focus lies in unravelling the intricate relationship between ion homeostasis, glycosylation, and protein trafficking under both physiological and pathological conditions, with a particular emphasis on renal diseases.

I conducted my Ph.D. thesis in Dr. Valverde’s lab (UPF) on the role of different asthma-associated proteins in controlling intracellular Ca2+ levels. During my Ph.D., I collaborated with Dr. von Blume (USA) to identify a new sorting mechanism at the Golgi; and with Dr. Hoth’s Lab (Germany) to hone my electrophysiological Ca2+ measurement techniques. Later, as a postdoctoral researcher in Dr. Malhotra’s lab (CRG), I led a team that unravelled how cells regulate mucins’ quality and quantities. From 2020 to 2022, I served as a senior researcher of the Renal Physiopathology Group (VHIR), where I studied the role of ion channels in rare renal diseases. Recently, I have been a visiting researcher at the Osaka International Cancer Institute, to deepen my knowledge on glycosylation (Japan); and at Leiden University (the Netherlands) to learn renal organoids’ generation.
My expertise in the field of ion channels is shown by my presentations at numerous scientific congresses and my high-impact publications (74 citations/year in the last 5 years). At present, I am director of a Ph.D. thesis and two Master Final Projects. Regarding my teaching experience, currently, I am professor of the Translational Biomedical Research Master at VHIR, where I am also the co-coordinator of the cardiovascular and kidney diseases module.
My involvement in the scientific community also includes being a member of the Dent Disease Foundation Medical Advisory Board (USA), review editor of Frontiers in Cell and Developmental Biology, and national and international grants’ evaluator. Referring to my merits, I was awarded with a Spanish Ph.D. mobility fellowship, the extraordinary Ph.D. award, a Juan de la Cierva fellowship, and a short-term EMBO fellowship. Furthermore, I have secured national and international funding, including grants from the Instituto de Salud Carlos III, the Mizutani Foundation for Glycoscience and the "Sociedad Española Contra el Cáncer".

Projects

Unravelling CIC-5 role on glycosylation and its link with proximal tubule functioning

IP: Gerard Cantero Recasens
Collaborators: -
Funding agency: Mizutani Foundation for Glycoscience
Funding: 45000
Reference: MIZUTANI FOUNDATION FOR GLYCOSCIENCE - 2022
Duration: 01/04/2023 - 31/03/2024

Related news

"Patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis present miRNA profiles in urinary extracellular vesicles associated with disease progression" was the awarded work.

Researchers at the VHIR have carried out a study showing that the ClC-5 protein regulates collagen levels through the β-catenin pathway and lysosomal degradation.

The research will perform a functional analysis of phenotype-modifying genetic variants in patients affected by familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (HFHNC).

Related professionals

Pablo Sanchez Sancho

Pablo Sanchez Sancho

Research technician
Basic, Translational and Clinical Pharmacy Research
Read more
Cristopher Alan Mazo Torre

Cristopher Alan Mazo Torre

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Patricia Bogdanov Baruj

Patricia Bogdanov Baruj

Postdoctoral researcher
Diabetes and Metabolism
Read more
Daniel Sánchez-Tejerin San José

Daniel Sánchez-Tejerin San José

Predoctoral researcher
Peripheral Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.